- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Humanised IgG4 monoclonal antibody against extracellular tau
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Humanised IgG4 monoclonal antibody against extracellular tau
| EU orphan designation number: | EU/3/15/1522
|
| Active ingredient: | Humanised IgG4 monoclonal antibody against extracellular tau |
| Indication: | Treatment of progressive supranuclear palsy |
| Sponsor: | Bristol-Myers Squibb Pharma EEIG
Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 30/07/2015 | Orphan designation | EMA/OD/044/15 | (2015)5429 of 28/07/2015 |
CONTACT
EU links
Directorate General Health & Consumers